Results 21 to 30 of about 17,216 (258)

The Kaplan–Meier estimator as a sum over units

open access: yesDiscover Data
A sum-wise formulation is proposed for the Kaplan–Meier product limit estimator of partially right-censored survival data. The population estimator is expressed as a sum over the individual units’ empirical and semi-empirical contributions, for observed ...
Malte C. Tichy
doaj   +1 more source

Asymptotic properties of Kaplan–Meier estimator and hazard estimator for censored survival time with LENQD data

open access: yesStatistical Theory and Related Fields
In this paper, we consider the estimators of distribution function and hazard rate for censored survival time. First, some properties and inequalities are established for linearly extended negative quadrant-dependent sequence as auxiliary results.
Yongming Li   +3 more
doaj   +1 more source

Pediatric Idiopathic Multicentric Castleman Disease Is Often Severe But Responsive to Siltuximab

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Idiopathic multicentric Castleman disease (iMCD) is a potentially fatal immunologic disorder marked by widespread lymphadenopathy and inflammation. Siltuximab, an interleukin‐6 (IL‐6) inhibitor, is the only FDA‐approved treatment for adult patients with iMCD.
Bridget Austin   +17 more
wiley   +1 more source

Robust bias estimation for Kaplan–Meier survival estimator with jackknifing [PDF]

open access: yesJournal of Statistical Theory and Practice, 2015
17 pages, 3 figures, 5 tables. CRiSM working paper, Paper No.
Khan, Md. Hasinur Rahaman   +1 more
openaire   +3 more sources

The Impact of the COVID‐19 Pandemic on Childhood Cancer Survival: A Population‐Based Assessment of Survival Patterns Between 2015 and 2023 in Germany

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Numerous international studies have reported declines in new cancer diagnoses, delayed diagnoses and disruptions in cancer treatment following the implementation of COVID‐19 pandemic public health measures, raising concerns that these effects may ultimately contribute to increased cancer mortality.
Friederike Erdmann   +8 more
wiley   +1 more source

Venetoclax‐Based Therapy as a Bridge to Hematopoietic Stem Cell Transplantation in Relapsed or Refractory Pediatric Acute Leukemia

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Relapsed and/or refractory (R/R) pediatric acute leukemia carries a dismal prognosis, largely driven by chemoresistance to conventional salvage therapy. The BH3‐mimetic venetoclax, combined with chemotherapy or hypomethylating agents, has demonstrated efficacy in small clinical trials.
Katherine S. Colman   +9 more
wiley   +1 more source

Bone and Soft Tissue Neoplasms in Infants Versus Older Children: A Report From the Cancer in Young People in Canada Program

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background and Aims Infant bone and soft tissue neoplasms present distinct clinical challenges and lack large‐scale data to inform treatment decisions. This study aims to characterize bone and soft tissue neoplasms in infants in Canada and to compare their outcomes with those of older pediatric patients.
Samuel Sassine   +21 more
wiley   +1 more source

Bandwidth Selection Problem for Nonparametric Regression Model with Right-Censored Data [PDF]

open access: yesRevista Română de Statistică, 2017
In this paper, the proposed estimator for the unknown nonparametric regression function is a Nadarya-Watson (Nadarya, 1964; Watson, 1964) type kernel estimator. In this estimation procedure, the censored observations are replaced by synthetic data points
Dursun AYDIN, Ersin YILMAZ
doaj  

ESTIMACIÓN DE KAPLAN MEIER BOOTSTRAP DE LA CURVA DE SUPERVIVENCIA

open access: yesPesquimat, 2014
In this work the function of survival is estimated by means of the non-parametric method known like the Kaplan Meier Bootstrap estimator, under the assumption of asymptotical normality.
Freddy Tineo Guevara   +2 more
doaj   +1 more source

Impact of Initial Treatment Setting on Survival in Relapsed Pediatric and AYA Bone Sarcomas: A Secondary Analysis of a Prospective Clinical Trial

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Outcomes in relapsed or refractory pediatric and AYA bone sarcomas remain poor, and the impact of early referral to specialized sarcoma centers on survival is unclear. Early centralization of care may improve local and systemic treatment quality, but evidence in this population is limited.
Justyna Antoniuk‐Majchrzak   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy